Literature DB >> 8076386

Psoriatic arthritis. Historical background and epidemiology.

T O'Neill1, A J Silman.   

Abstract

Psoriatic arthritis was first described in the early part of the nineteenth century. Over the past 50 years, concepts of the disease have evolved as a result of clinical, epidemiological, radiological and immunogenetic study. Epidemiological and clinical investigations suggest that the disease is a unique arthropathy rather than the coincident occurrence of two common diseases. There are no validated criteria for classification; this is partly because of the heterogeneous clinical features associated with the disease, and the relapsing and remitting nature of both psoriasis and arthritis. Clinical subgroups have been proposed and have proved useful in study of the disease; however, there are inconsistencies and overlaps in the published data. The population prevalence of psoriatic arthritis is in the range of 2-10 per 10,000 although this is probably an underestimate as those with sacroiliac involvement only are not included. There are currently no incidence figures from population samples. The disease is slightly more common in females than males, although there is variation in the sex ratio by disease subgroup. There is evidence that hormonal and environmental factors play a role in the occurrence of disease.

Entities:  

Mesh:

Year:  1994        PMID: 8076386     DOI: 10.1016/s0950-3579(94)80017-0

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  18 in total

1.  Human leukocyte antigen (HLA)-C polymorphisms are associated with a decreased risk of rheumatoid arthritis.

Authors:  Yiqun Zhang; Hui Zhang; Yong Huang; Rongbin Sun; Ruiping Liu; Jie Wei
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

2.  Early detection of spondyloarthropathy in patients with psoriasis by using the ultrasonography and magnetic resonance image.

Authors:  Maha Hamdy; Gihan Omar; Rawhya R Elshereef; Abdou S Ellaban; Mohamed Amin
Journal:  Eur J Rheumatol       Date:  2015-03-01

Review 3.  Psoriatic arthritis: a critical review.

Authors:  Varun Dhir; Amita Aggarwal
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 4.  Psoriatic arthritis: Epidemiology, diagnosis, and treatment.

Authors:  Jung-Tai Liu; Horng-Ming Yeh; Shyun-Yeu Liu; Kow-Tong Chen
Journal:  World J Orthop       Date:  2014-09-18

Review 5.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Diagnosis and management of psoriatic arthritis.

Authors:  John Brockbank; Dafna Gladman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.

Authors:  Floranne C Wilson; Murat Icen; Cynthia S Crowson; Marian T McEvoy; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-02-15

Review 8.  Development of diagnostic criteria for psoriatic arthritis: methods and process.

Authors:  William J Taylor; Philip S Helliwell
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

9.  Synovial tissue hypoxia and inflammation in vivo.

Authors:  C T Ng; M Biniecka; A Kennedy; J McCormick; O Fitzgerald; B Bresnihan; D Buggy; C T Taylor; J O'Sullivan; U Fearon; D J Veale
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

10.  Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.

Authors:  M Feletar; J E Brockbank; C T Schentag; V Lapp; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.